Stockwinners Market Radar for August 12, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:07 EDT Intra-Cellular director Marcus sells 10,000 common shares - In a regulatory filing, Intra-Cellular director Joel Marcus disclosed the sale of 10,000 common shares of the company on August 11 at a price of $59.22 per share.

18:01 EDT Algoma Steel confirms USW Local 2251 agree to take offer to employees for vote - Algoma Steel announced that United Steelworkers Local 2251 have agreed to take the company's last offer to a vote by employees in the affected bargaining unit. Operations will continue in the ordinary course during the voting process, and the Union has agreed to provide advance notice to the company to allow for a safe and orderly shutdown of operations in the event the Union instructs employees to go on strike. Algoma President and Chief Executive Officer Michael Garcia commented. "We respect the collective bargaining process and are pleased that our employees will have their say on a matter of such critical importance to their livelihoods, the lives of their families, and fellow community members. The Company has offered a non-concessionary, top-of-market wage and benefit package which includes a 5.5% wage increase, continuation of COLA, significant improvements in pensions and benefits for employees, and enhanced retiree benefits over a four-year term that delivers the stability needed to ensure a successful transition to electric arc steelmaking. A signing bonus is also included contingent upon no disruption to operations and uninterrupted shipments to our customers."

17:59 EDT Insperity COO Arizpe sells 5,000 common shares - In a regulatory filing, Insperity president and COO Arthur Arizpe disclosed the sale of 5,000 common shares of the company on August 10 at a price of $110 per share.

17:27 EDT PlayAGS jumps nearly 4% to almost $8 after confirming receipt of offer

17:25 EDT Raytheon Technologies awarded $132.65M Air Force contract modification - Raytheon Technologies has been awarded a $132.65M modification to a previously awarded contract for engine module remanufacture. This contract provides for F100-PW-100/-200/-220/-220E/-229/-229EEP engine module remanufacture for Foreign Military Sales, or FMS, partner countries. Work is expected to be completed by August 14, 2023. This contract involves FMS to Chile, Indonesia, Taiwan, Poland, Greece, Iraq, Pakistan, Romania, Saudi Arabia, Egypt, Thailand and Morocco. This modification was the result of a sole source acquisition. The Air Force is the contracting activity.

17:24 EDT Lockheed Martin awarded $7.63B Navy contract modification - Lockheed Martin was awarded a not-to-exceed $7.63B firm-fixed-price, fixed-price incentive, undefinitized modification to a previously awarded advanced acquisition contract. This modification increases the ceiling to procure 129 Lot 15 aircraft. Work is expected to be completed in October 2024. In total, $87.09M of funds will expire at the end of the current fiscal year. The Naval Air Systems Command is the contracting activity.

17:18 EDT Macom to replace SailPoint in S&P 400 at open on 8/17 - Thoma Brava is acquiring SailPoint Technologies Holdings in a deal expected to be completed soon pending final conditions.

17:15 EDT Emergent BioSolutions receives FDA warning letter about Camden facility - According to a regulatory filing, Emergent BioSolutions said it received a communication from the FDA on August 10, 2022 that included the issuance of a warning letter with respect to the company's Camden manufacturing facility in Baltimore, Maryland. The warning letter cites two areas of deficiencies as follows: systems for cleaning and maintenance of equipment to prevent contamination of drug product, specifically related to particulates from the metal trays, and; processes and practices surrounding aseptic processing. In addition, the FDA recommended the company review and assess its Quality Management System and engage a consultant with respect to Current Good Manufacturing Practices. While waiting for FDA's response related to a February 2022 inspection of the facility, the company retained a third party for additional review of the facility and to provide additional oversight of processes for product release. The company remains committed to upgrading its physical capabilities and strengthening its culture of quality and compliance.

17:11 EDT Alarm.com CFO Valenzuela sells 6,820 common shares - In a regulatory filing, Alarm.com CFO Steve Valenzuela disclosed the sale of 6,820 common shares of the company on August 12 at a price of $75.60 per share.

17:04 EDT Azure Power delays filing Annual Report on Form 20-F - Azure Power announced that it will not be in a position to file its Annual Report on Form 20-F for the fiscal year ended March 31 with the U.S. SEC by August 16, as extended from the original due date of August 1, pursuant to the Form 12b-25 filed with the SEC on August 1. The delay in filing the 2022 Form 20-F is due to company's ongoing review of its internal control and compliance framework. These matters are being progressed with the assistance of the company's advisers. The company is making all efforts to file its 2022 Form 20-F as soon as practicable. The company does not expect the delay in filing its 2022 Form 20-F to impact its ongoing renewable energy business operations. Azure's new leadership, supported by the Board, will be upgrading the company's processes going forward.

16:50 EDT Legacy Housing receives noncompliance notice from Nasdaq - Legacy Housing received a notice from Nasdaq stating that because the company has not yet filed its quarterly report on Form 10-Q for the period ended June 30, the company remains in non-compliance with Nasdaq Listing Rule 5250, which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. As announced on May 17, the company had previously received a notice from Nasdaq indicating that as a result of not having timely filed its quarterly report on Form 10-Q for the period ended March 31, it was not in compliance with Nasdaq Listing Rule 5250. On May 31, 2022, the company submitted to Nasdaq a plan to regain compliance with the Listing Rule 5250 with respect to the Form 10-Q1.

16:41 EDT Soros adds Biohaven, exits Lucid in Q2 - George Soros' Soros Fund Management disclosed in an SEC filing its holdins as of June 30, 2022. The fund's 27 new buys during the second quarter included, by size of position, Biohaven Pharma (BHVN), Alleghany (Y), GCP Applied Technologies (GCP), Turning Point Therapeutics (TPTX), and Tesla (TSLA). Soros exited 31 holdings during the quarter, including by size of previous position iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), Lucid (LCID), TJX (TJX), MGM Resorts (MGM), and Didi Global (DIDIY). The fund increased its stake in 22 holdings, including by size of previous position Salesforce (CRM), Indie Semiconductor (INDI), T-Mobile (TMUS), Qualcomm (QCOM), and TransDigm (TDG). Soros reduced its stake in 16 holdings, including by size of previous position Rivian (RIVN), Liberty Broadband Class C (LBRDK), JPMorgan (JPM), DR Horton (DHI), and Airbnb (ABNB). The fund's top holdings as of June 30, in order of size, were Rivian, Amazon (AMZN), Liberty Broadband Class C, DR Horton, and Biohaven.

16:35 EDT LMP Automotive Holdings Inc trading resumes

16:31 EDT Mohawk Industries exec Thiers sells 8,000 common shares - In a regulatory filing, Mohawk Industries president of Flooring ROW Bernard Thiers disclosed the sale of 8,000 common shares of the company on August 12 at a price of $126.25 per share.

16:16 EDT Badger Meter raises quarterly dividend 12.5% to 22.5c from 20c per share - The increased dividend is payable September 9 to shareholders of record on August 26.

16:08 EDT LMP Automotive to voluntarily delist from Nasdaq - LMP Automotive announced that in connection with the previously announced sale of substantially all of its assets, it has notified Nasdaq of the company's intent to voluntarily delist its common stock from Nasdaq. The company expects to file a Form 25 with the Securities and Exchange Commission to effect the voluntary delisting of the common stock under Section 12 of the Securities Exchange Act of 1934, as amended on or about August 15 and that the delisting will be effective on or about August 25, ten days after the filing of the Form 25. Following delisting, the company expects its common stock to trade on the OTC Pink Market tier.

16:01 EDT Latch receives expected Nasdaq notification of non-compliance - Latch announced that on August 11, 2022, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the company that it did not comply with Nasdaq's Listing Rule 5250(c)(1) for continued listing because the company had not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 by the required due date. The company previously disclosed its inability to timely file the Form 10-Q in its Notification of Late Filing on Form 12b-25 filed with the Securities and Exchange Commission on August 10, 2022.

15:02 EDT Inspired says does not comment on 'rumors or speculation' after PlayAGS reports - Inspired Entertainment (INSE) noted recent speculation in the press and financial markets regarding a potential transaction with PlayAGS (AGS), stating that "as a matter of policy, Inspired does not comment on market rumors or speculation."

14:56 EDT Essential Utilities subsidiary acquires municipal wastewater assets for $55M - Essential Utilities announced that its Pennsylvania wastewater subsidiary has acquired the municipal wastewater assets of East Whiteland Township, Chester County for approximately $55M. Aqua Pennsylvania President Marc Lucca said, "We look forward to providing excellent service to the East Whiteland community and have already identified the need for $17 million in infrastructure improvements over the next decade including two major sewer extensions. That work will likely begin with the Planebrook and Bacton Hill roads' sewer extensions," said Aqua Pennsylvania President Marc Lucca.

13:21 EDT L.B. Foster unit acquires VanHooseCo precast operating assets for $50.5M - L.B. Foster announced that its wholly-owned subsidiary, CXT Incorporated, has acquired the operating assets of VanHooseCo Precast LLC, a privately-held business headquartered in Loudon, Tennessee specializing in precast concrete walls, water management products, and traditional precast products for the industrial, commercial and residential infrastructure markets. VanHooseCo's ~100 employees will be retained by CXT at VanHooseCo's existing manufacturing site in Loudon, near Knoxville, and a new facility being commissioned in Lebanon, TN near Nashville. Revenues for VanHooseCo's most recently completed fiscal year ended December 31, 2021 totaled ~$28M, with net income of $1.4M and adjusted EBITDA of ~$7.2M. Under the terms of the definitive Asset Purchase Agreement between CXT and VanHooseCo, the company paid $50.5M for the business, subject to holdbacks for customary indemnification and retention obligations and a post-closing working capital adjustment. In connection with the Transaction, the company also entered into a license agreement for the ENVIROCAST pre-insulated concrete walls and ENVIROKEEPER water retention and management product lines.

13:15 EDT PlayAGS trading halted, news pending

13:01 EDT Baker Hughes reports U.S. rig count down 1 to 763 rigs

12:33 EDT PlayAGS trading resumes

12:21 EDT Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 - Warner Bros. Discovery (WBD) said that its upcoming video game based on the "Harry Potter" franchise "Hogwarts Legacy" will launch on February 10, 2023 for PlayStation (SONY), Xbox (MSFT), and PC. The Nintendo Switch (NTDOY) launch date will be revealed soon, the company noted. "The team is excited for you to play, but we need a little more time to deliver the best possible game experience," the company said. Reference Link

12:00 EDT SmartRent falls -32.7% - SmartRent is down -32.7%, or -$1.83 to $3.77.

12:00 EDT CS Disco falls -54.0% - CS Disco is down -54.0%, or -$15.64 to $13.32.

12:00 EDT Xponential Fitness rises 21.1% - Xponential Fitness is up 21.1%, or $3.44 to $19.73.

11:54 EDT UPS pilots ratify two-year contract extension - In voting that closed today, the Independent Pilots Association announced that its members have overwhelmingly ratified a two-year pilot contract extension with UPS. UPS pilots approved the agreement with 90.72% voting in favor with 97.1% of those eligible participating in the balloting. The short-term extension provides for contractual improvements in pilot compensation and retirement. The new agreement extends the term of the pilot contract until September 1, 2025. The IPA is the collective bargaining unit representing the more than 3,300 professional pilots who fly for UPS.

11:12 EDT Apexigen Inc trading halted, volatility trading pause

10:09 EDT L&F Acquisition Corp trading halted, volatility trading pause

10:00 EDT Olo falls -27.6% - Olo is down -27.6%, or -$3.58 to $9.41.

10:00 EDT ESS Inc. rises 14.6% - ESS Inc. is up 14.6%, or 61c to $4.79.

10:00 EDT Xponential Fitness rises 22.6% - Xponential Fitness is up 22.6%, or $3.68 to $19.97.

09:53 EDT Phunware drops 7% following Q2 report - Shares of Phunware are down 12c, or 7%, to $1.62 after the company last night reported results for the quarter ended June 30. Net revenues for the second quarter totaled $5.5M, up from $1.44M a year ago, and net loss per share was (17c), inclusive of (12c) per share impairment of digital assets, versus a loss per share of (11c) in the same quarter of last year. Alan Knitowski, President, CEO and Co-Founder of Phunware, said: "After previously guiding investors to an upwardly revised top-line revenue growth exceeding 275% year-over-year for Q2, we are thrilled to have outperformed that target with a new second quarter record for reported revenues as a public company, delivering actual revenues exceeding 282% growth to close the first half of our fiscal year. We continue operating effectively at the intersection of mobile, cloud, big data and blockchain across all lines of business and continue to activate our MaaS Loyalty and Rewards ecosystem through PhunWallet, PhunToken, PhunCoin and PhunVerse, commercializing a truly decentralized global data economy in both the physical and virtual worlds. Importantly, and in tandem, we are reiterating our forward revenue guidance for 2022 of up roughly 250% year-over-year, or $25M. In parallel, we also expect that the back-end of 2022 will represent a new second half record for reported revenues as a public company for its comparable period." Matt Aune, CFO of Phunware, added: "We continued to build on the momentum from Q1 by posting our largest revenue Q2 quarter as a public company. In addition to the outstanding top line growth of 282% year-over-year, we continued to invest in the business to further bolster our product offerings and enable us to deliver our solutions even faster and more efficiently. We are pleased with the sequential improvements made to our gross margins and expect to see continued improvement as we bring the new Lyte by Phunware facility online in Q3 in Austin. Rolling forward, we expect to close the third quarter strong sequentially, activate PhunCoin for trading on Securitize and continue to deliver dramatic year-over-year growth for the remainder of the fiscal year."

09:47 EDT SmartRent falls -19.5% - SmartRent is down -19.5%, or -$1.09 to $4.51.

09:47 EDT CS Disco falls -48.4% - CS Disco is down -48.4%, or -$14.01 to $14.96.

09:47 EDT ESS Inc. rises 10.0% - ESS Inc. is up 10.0%, or 42c to $4.60.

09:45 EDT Zhong Yang Financial Group Ltd trading halted, volatility trading pause

09:38 EDT WeTrade Group Inc trading resumes

09:36 EDT Innodata trading resumes

09:35 EDT Apyx Medical trading resumes

09:33 EDT 4D Molecular Therapeutics trading halted, volatility trading pause

09:32 EDT Co-Diagnostics trading halted, volatility trading pause

09:31 EDT TGL Stock trading halted, volatility trading pause

09:27 EDT Novavax's Nuvaxovid COVID-19 vaccine approved in South Korea for adolescents - Novavax partner,SK bioscience has received a Post Approval Change Application approval from the Korean Ministry of Food and Drug Safety for Nuvaxovid COVID-19 vaccine for active immunization to prevent COVID-19 in adolescents aged 12 through 17. The approval was based on data from the ongoing pediatric expansion of the Phase 3 PREVENT-19 trial in the U.S. In the trial, Nuvaxovid achieved its primary effectiveness endpoint and demonstrated 80% clinical efficacy overall at a time when the Delta variant was the predominant circulating SARS-CoV-2 strain in the U.S. Preliminary safety data showed the vaccine to be generally well-tolerated. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups, and not considered related to the vaccine. The most common adverse reactions observed were injection site tenderness/pain, headache, myalgia, fatigue, and malaise. There was no increase in reactogenicity in younger adolescents compared to older adolescents. In the 12 through 17 year-old population, Nuvaxovid has been granted authorization in India, the European Union, Australia, Thailand, and Japan, and is under review in other markets. In Korea, SK bioscience signed a licensing agreement with Novavax and is manufacturing drug substance and drug product of Nuvaxovid for domestic use.

09:07 EDT Volcon off-road UTV to be powered by General Motors' electric propulsion system - Volcon (VLCN) announced that it will power all of its off-road utility terrain vehicles with General Motors' (GM) proven and tested electric propulsion systems, including the Company's flagship UTV, the Volcon Stag, which was revealed to the public on July 1, 2022. Future models, including future versions of the Stag, as well as the Company's planned "Project X" vehicle, will be designed and developed to utilize GM's electric propulsion systems. Volcon will be the first, and currently only off-road powersports company to offer their full line of vehicles with GM's electric propulsion. "General Motors has transformed from an automaker to a platform innovator, with scalable architectures designed to accelerate EV adoption across different industries and product types," said Travis Hester, GM Vice President of EV Growth Operations. "Our work with Volcon is indicative of our plans and demonstrates the flexibility of the platform as well as potential applications well beyond traditional vehicles." In addition to battery cell modules, the Stag will use a number of supporting components from GM. The GM propulsion system will provide instant high power and torque, with AWD capabilities, enabling the Stag to have exceptional acceleration and speed recovery in a variety of terrains. Variable driving modes will allow the driver to adjust the power delivery to optimize performance or range according to the needs.

09:05 EDT Greenpro Capital conducts unicorn incubation program - Greenpro Capital announced its unicorn incubation program has been successfully conducted in Malaysia. SEA Unicorn 2022 program ran from March to July 2022. A total of 124 emerging growth companies has actively participated in the program. 10 companies have been selected as the finalists with plans to go public in the US Capital Market.

09:03 EDT Arcimoto appoints Fittipaldi as interim CEO - Arcimoto announced that Jesse Fittipaldi has been appointed to the role of Interim CEO. Fittipaldi joined Arcimoto in 2015 as the company's Business Development Lead. From 2017 to 2020, Fittipaldi was Vice President of the Company and had been serving as Chief Strategy Officer since 2020. Founder Mark Frohnmayer has been named Chief Vision Officer. Frohnmayer founded Arcimoto in 2007 and oversaw Arcimoto's growth from a boutique R&D studio to a leading three-wheel electric vehicle manufacturer.

08:57 EDT Mobiquity Technologies announces launch of 12-month campaign for Bitburn - Mobiquity Technologies launched an exclusive 12-month advertising campaign for Bitburn, the first ever true burn tokenomics to foster mass adoption. Bitburn Rewards are automatically deployed to holders according to buy and sell volume. The formula is simple-the more Bitburn tokens you hold, the more Bitcoin rewards you will earn. Bitburn resides on the BSC network and rewards 5% Bitcoin while offering true burn.

08:49 EDT DriveItAway launches Escape PHEV subscription to ownership program - DriveItAway Holdings announced that it recently launched its electric vehicle subscription to ownership program with the Ford Escape Plug-In Hybrid, working with a new dealer partner, the Chapman Auto Group. Focused on enabling all who want the benefits of immediately driving and owning an electric vehicle, DriveItAway is now rolling out the Ford Escape Plug-In Hybrid in conjunction with Chapman Auto stores, with eight locations in the greater Philadelphia/New Jersey/Delaware region.

08:40 EDT MVB Financial to acquire Integrated Financial in an all-stock transaction - MVB Financial announced that it has entered into a definitive merger agreement pursuant to which MVB will acquire Integrated Financial Holdings in an all-stock transaction. The strategic combination is expected to accelerate a fast track growth vehicle for MVB by expanding its government guaranteed lending business, including SBA and USDA originations and servicing. IFH is headquartered in Raleigh, North Carolina, and is the parent company of five wholly owned subsidiaries, including West Town Bank & Trust and Windsor Advantage. WTBT had approximately $435M in total assets, $326M in loans and $334M in deposits as of June 30. Since 2018, WTBT's Government Guaranteed Lending Team has originated more than $1B in loans. Under the terms of the merger agreement, IFH shareholders will receive 1.21 shares of MVB common stock for each share of IFH common stock. Based on the closing price of MVB stock of $34.54 on August 11, the implied per share purchase price is $41.79, with an aggregate transaction value of approximately $98M. The transaction is expected to be immediately accretive to tangible book value per share at closing and approximately 15% accretive to earnings per share in 2023. MVB also expects tangible common equity to tangible assets and all regulatory capital ratios to increase pro forma for the transaction. Upon closing of the transaction, IFH President and CEO Eric Bergevin will join MVB's executive leadership team as a direct report to CEO Larry Mazza. Riddick Skinner, EVP, government lending for IFH, and Michael Breckheimer, EVP, corporate strategy for IFH, will report to Bergevin. The transaction with IFH has been unanimously approved by both IFH's and MVB's boards of directors and is expected to be completed in the first quarter of 2023, subject to approval of both companies' shareholders, regulatory approvals and the satisfaction of other customary closing conditions.

08:38 EDT Ecoark Holdings provides update to investors on recent transactions - Ecoark announced executive management's communication to its shareholders of the Company's strategy to spin off its non-core subsidiaries to maximize the generation of shareholder value. As of the market close on August 11, 2022, Ecoark had a closing share price of $1.97 per share and market cap of approximately $52.14 million dollars. On July 25, 2022, Ecoark executed a definitive agreement to sell its exploration and production business, White River Holdings Corp to Fortium Holdings Corp in an all-stock transaction for $30,000,000 of convertible preferred stock. On August 11, 2022, Ecoark executed a definitive agreement to sell its cryptocurrency mining business, Agora Digital Holdings to HUMBL in an all-stock transaction for $60,000,000 of convertible preferred stock; the transaction is subject to various closing conditions which Ecoark believes will close in August 2022. Furthermore, on August 11, 2022, Ecoark entered into a non-binding letter of intent to divest its oilfield services business, Banner Midstream, in an all-stock transaction to a confidential public company also engaged in oilfield services; further details will be disclosed to shareholders at the time of the execution of the reverse merger agreement which Ecoark expects to occur in August 2022. Upon the successful closing of all transactions, Ecoark plans to move forward with the acquiring companies to have registration statements filed to register the underlying shares of common stock for each series of common or preferred stock and then execute a stock dividend to distribute 100% of the fully converted shares of common stock to all Ecoark shareholders of record as of a future to be determined record date. "As a diversified holding company, Ecoark's executive team and Board of Directors are constantly monitoring the Company's market cap versus our own estimated value of our underlying subsidiaries to assess whether the Company is fairly valued or not as a publicly traded company," stated Randy May, Chairman and CEO of Ecoark. "Our belief, based on our current market cap, is that the market as a whole is valuing Ecoark almost entirely based on the prospects of our core subsidiary, Zest Labs, Inc. We feel, however, that the recently announced transactions of the divestitures of White River, Agora Digital, and Banner Midstream which are expected to generate approximately $100,000,000 in closing value prior to stock dividends are the most efficient manner for the Company to generate long-term shareholder value. We believe that the holding company model is no longer viable when the sum of all subsidiaries is significantly greater than the Company's current market cap."

08:34 EDT Acer Therapeutics, Relief receive orphan drug designation for ACER-001 - RELIEF THERAPEUTICS Holding (RLFTF) and its collaboration partner, Acer Therapeutics (ACER) announced that the European Commission has granted orphan medicinal product designation in the EU to ACER-001 for the potential treatment of patients with Maple Syrup Urine Disease, ACER-001 was granted orphan drug designation by the U.S. Food and Drug Administration in the U.S. for MSUD in 2014.

08:11 EDT Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx - Guardant Health (GH) announced that the FDA has approved its Guardant360 CDx liquid biopsy test as a companion diagnostic, or CDx, to select patients with unresectable or metastatic HER2-mutant non-small cell lung cancer, or NSCLC, whose tumors have activating HER2 mutations for treatment with Enhertu, a HER2-directed antibody drug conjugate jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (AZN).

08:09 EDT Rubicon sets record date for its $11 per share cash distribution - Rubicon Technology announced that, in connection with the cash tender offer by Janel Corporation for up to 45% of Rubicon's issued and outstanding common stock, par value $.001 per share, the Company's Board of Directors has set August 23, 2022 as the record date for its cash distribution of $11.00 per share of Common Stock. The Distribution and the Record Date are conditioned upon the consummation of the Offer by August 19, 2022. If such condition has occurred it is anticipated that the Distribution will be paid on or about August 29, 2022. The payment of the Distribution represents more than 25% of the price per share of Common Stock and therefore NASDAQ has determined that the Common Stock will trade with "due bills," representing an assignment of the right to receive the Distribution during the period from the Record Date to the ex-dividend date.

08:08 EDT XpresSpa announces re-opening of XpresSpa location at JFK Airport - XpresSpa Group announced the re-opening of one of its top-performing XpresSpa locations at John F. Kennedy, JFK, International Airport's Terminal 4. Located in Terminal 4 near Gate B22, the re-opened XpresSpa will provide traditional wellness services, such as neck and back massage, as well as solutions incorporating technology that gives therapeutic relief with minimal intervention. "We are thrilled to re-open one of our most popular locations which offers a retreat for travelers seeking a more relaxing environment in one of the busiest airports in the world," said XpresSpa Group CEO Scott Milford. "As travelers return to airports, XpresSpa is dedicated to providing exceptional wellness experiences for people on-the-go. We thank our partners at JFK for their ongoing support and look forward to building on our success domestically and abroad as we continue to relaunch and debut new spas internationally." XpresSpa currently operates 26 locations globally.

08:07 EDT SciSparc issued Israeli patent for tech treating CNS disorders - SciSparc announced it has been granted an Israeli patent for its core technology that treats central nervous systems, CNS, disorders. The invention relates to "Pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions." "Our IP portfolio continues to grow, and it is one of our greatest and most important assets which distinguishes us from other companies operating in the field," said Adi Zuloff-Shani, PhD, Chief Technologies Officer of SciSparc. "This is now the fifth recent patent grant we have received related to our core technology, with patents previously issued in the U.S., Australia and Japan. This grant further solidifies the strength of our intellectual property protections and aligns well with our overarching patent filing strategy."

08:05 EDT Vontier appoints Anshooman Aga as CFO - Vontier (VNT) announced the appointment of Anshooman Aga as CFO, effective August 29. Aga succeeds David Naemura, who will remain with the company through year end and work closely with Aga and other members of the executive team to facilitate a transition. Most recently, he served as senior VP and CFO of Harsco (HSC) from August 2021 through August 2022.

07:33 EDT Marathon Gold reports Q2 capex C$9.2M vs. C$4.7M last year - Matt Manson, President, and CEO commented: "During the second quarter and into the summer, our preparations for the development of the Valentine Gold Project continued with progress on our financing, permitting, engineering and project execution arrangements. Important milestones were achieved with the completion of the public and regulatory review stages of our federal Environmental Assessment, the execution of our Benefits Agreement with the province of Newfoundland and Labrador, the issuance of our Mining and Surface Leases, and the publication of our first annual Sustainability Report. At time of writing, we are awaiting a final Decision Statement by the Minister of Environment and Climate Change Canada which, if positive, will mark the completion of our overall Environmental Assessment process and permit site activities to commence. Alongside this development work, in early July, we were pleased to have announced an increase to the Project's Mineral Resource Estimate in each of tonnes, grade and ounces. Our Updated Feasibility Study, under preparation for completion in the fourth quarter, will assess the opportunities presented by this larger resource inventory to the Project's Mineral Reserves, production profile and mine life, as well as provide an updated capital and operating cost estimate. The Valentine Gold Project will be the most significant new mining project in Newfoundland and Labrador in recent years, and with our strong treasury at quarter-end, we look forward to commencing our early works later this quarter, with permits in hand."

07:22 EDT ARC Group says RM2 continues to experience 'record demand' for BLOCKPal pallets - ARC Group Worldwide provides a trading update. The company said, "RM2 continues to experience record demand for its BLOCKPal pallets, and is working diligently on the Company's production ramp up, further expanding its ability to provide more pallets to customers. Retailers' and suppliers' demand for the pallets stems from the need for smart and higher performance pallets, coupled with their desire to remove wooden pallets from their supply chains. Demand currently outstrips supply, and the Company is focused on increasing production capacity by further enhancing production processes. The Company has maintained gross margins against the headwinds of inflationary pressures. This steady margin, combined with increased pallet deployments, has enabled to the Company to become EBITDA positive for the month in June 2022. Further EBITDA improvement is expected through increasing density in RM2's pooling loops." Separately, the Company also announces that, pursuant to the Share Exchange Agreement dated July 6, 2021 relative to the business combination, as certain metrics were not achieved as of July 2022, the relative valuations of the combining entities were adjusted, leading to the cancellation of 11,594,619 escrowed ARC Group Worldwide, Inc. shares held by historical RM2 shareholders. As a result of this cancellation, as of the date hereof there are 116,099,776 shares of Common Stock issued and outstanding on a fully diluted basis, of which 14,931 are held in Treasury.

07:20 EDT Unity: UBX1325 injection led to clinically meaningful improvement in mean BCVA - UNITY Biotechnology announced 12- and 18-week data from its Phase 2 BEHOLD study of UBX1325, a senolytic Bcl-xL inhibitor, in patients with diabetic macular edema. At 18 weeks after a single UBX1325 injection, the mean change in BCVA of UBX1325-treated subjects was an increase of 6.1 ETDRS letters, representing an improvement of +5.0 ETDRS letters compared to sham-treated subjects. In addition, patients treated with UBX1325 maintained CST compared to sham-treated patients who demonstrated progressive worsening of CST through 18 weeks. The separation of UBX1325-treated patients from sham-treated patients at 18 weeks in measures of both visual function and retinal structure following a single UBX1325 injection suggests that one dose could have a durable therapeutic effect. The current standard of care for DME with the leading anti-VEGF therapeutic requires 3-5 monthly loading doses followed by every 8-week dosing, imposing a significant treatment burden on patients. Evidence of favorable safety, visual acuity improvement, and structural stability in a difficult-to-treat patient population: Overall Safety: UBX1325 demonstrated a favorable safety and tolerability profile with no cases of intraocular inflammation, retinal vein occlusion, endophthalmitis, or vasculitis. At 12 weeks" Patients enrolled in BEHOLD were receiving regular anti-VEGF treatment prior to enrollment into the study with the last anti-VEGF injection occurring 3 - 6 weeks prior to randomization. Patients treated with a single injection of UBX1325 had a mean improvement in BCVA of +4.7 ETDRS letters from baseline compared to +1.3 ETDRS letters in sham-treated patients. Patients treated with UBX1325 had a mean change in CST of -1.4 microns from baseline compared to +40.3 microns in sham-treated patients. At 18 weeks: Patients treated with UBX1325 had a mean improvement in BCVA of +6.1 ETDRS letters from baseline compared to +1.1 EDTRS letters in sham-treated patients. Patients treated with UBX1325 had a mean change in CST of +3.2 microns from baseline compared to +53.5 microns in sham-treated patients. Based on pre-defined proof-of-concept criteria of alpha=0.15, the study demonstrated a statistically significant treatment effect for both BCVA and CST at both 12- and 18-weeks. The proof-of-concept Phase 2 BEHOLD study is a multi-center, randomized, double-masked, sham-controlled study designed to evaluate the safety, tolerability, efficacy and durability of a single 10 mcg dose of UBX1325 in patients with DME evaluated though 24 weeks. The study enrolled 65 patients being actively treated with anti-VEGF who had a visual acuity deficit and residual retinal fluid. Patients have the option of rolling over to a 48-week long term extension and a majority of patients who have completed their 24-week visit have opted to remain in the study.

07:17 EDT PLx Pharma announces survey data on VAZALORE 81 mg - PLx Pharma, with its lead products VAZALORE 81 mg and VAZALORE 325 mg liquid-filled aspirin capsules, announced positive findings from its initial VAZALORE 81 mg Patient Experience Survey. Between April and June 2022, PLx Pharma distributed Patient Experience Survey kits to high-volume cardiology offices nationwide, where physicians are actively recommending VAZALORE 81 mg for the secondary prevention of cardiovascular disease. The kits included a VAZALORE 81 mg product sample, product literature and a high-value coupon. Physicians provided the survey kits to patients they deemed appropriate for daily aspirin use. Results from 130 respondents through August 3, 2022, showed that 95% of patients are satisfied with VAZALORE and 90% intend to purchase the product. Key Findings: 97% felt they are doing all they can to help support their heart health; 96% felt no issues with their stomach when taking, either with or without food; 96% are likely to remember to take VAZALORE every day; 98% said VAZALORE is easy to swallow; 95% satisfied with VAZALORE as their aspirin therapy choice; 90% intend to purchase. "These real-world results, gathered from patients who have taken VAZALORE 81 mg, are very promising and indicative of the potential uptake of the brand and its importance in the treatment of secondary prevention of cardiovascular events for millions of patients," said Natasha Giordano, President & CEO of PLx Pharma.

07:10 EDT HCW Biologics expects cash to fund operations through end of 2023 - On June 30, 2022, the Company's cash balance was $42.1 million, consisting of $15.4 million in cash and cash equivalents, $17.0 million in short-term investments, and $9.7 million in long-term investments. Investments are all U.S. Treasury bills or notes. The Company estimates that the current cash balance, along with a commitment for a term facility for the purchase of the Company's new headquarters, is sufficient to fund operations and capital expenditures through the end of 2023.

07:07 EDT Rapid Micro Biosystems announces review of strategic alternatives - Rapid Micro Biosystems announced that its Board of Directors has initiated a review of strategic alternatives to maximize shareholder value. The Board has retained Morgan Stanley & Co. LLC as its financial advisor and Goodwin Procter as its legal advisor to assist in its review of a wide range of options including, among other things a sale, merger or other strategic transaction. In addition, the Company announced that its Board of Directors has unanimously rejected an unsolicited non-binding proposal from Kennedy Lewis Investment Management to acquire all of the outstanding shares of the Company for $5.00 per share in cash. Following a comprehensive review, in consultation with its financial and legal advisors, the Board determined that the proposal is inadequate and is not in the best interest of the Company or its shareholders. "The Company is taking decisive action to right-size its cost structure to allow continued focus on enhanced commercial execution and key product development initiatives while also managing its significant cash balance and long cash runway," said Jeffrey Schwartz, Chairperson of the Board of Directors. "As we seek to accelerate this work and best position our business for the future, the Board believes now is the right time to explore alternatives to determine the best path to maximize shareholder value. The Board is committed to exploring a range of alternatives, while simultaneously prioritizing and advancing important initiatives within the business, that we believe will enhance value for our shareholders."

07:05 EDT Iterum Therapeutics expects cash to fund operations into 2024 - Cash, cash equivalents and short-term investments was $68.9 million at June 30, 2022. Based on the current operating plan, Iterum expects that its current cash, cash equivalents and short-term investments will be sufficient to fund its operations into 2024. As of July 31, 2022, Iterum had approximately 183.5 million ordinary shares outstanding.

07:05 EDT Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction - The Company is implementing an organizational restructuring plan to right-size its cost structure based on its lowered 2022 outlook. The Company will continue to invest in key growth initiatives including enhancing commercial execution and key product development programs that are expected to drive future revenue growth. The plan involves an approximately 20% reduction in the Company's workforce, which is largely focused on non-commercial functions. The Company expects the organizational restructuring plan to result in approximately $8.0 - $9.0 million in annualized cost savings by the first quarter 2023. It expects to incur restructuring charges of approximately $1.5 million to be recognized in the third quarter of fiscal year 2022.

06:58 EDT Brookfield Business Partners to renew normal course issuer bid - Brookfield Business Partners announced that the Toronto Stock Exchange has accepted a notice filed by Brookfield Business Partners of its intention to renew its normal course issuer bid for its limited partnership units. Brookfield Business Partners believes that in the event the units trade in a price range that does not fully reflect their value, the acquisition of units may represent an attractive use of available funds. The Board of Directors of the general partner of Brookfield Business Partners authorized the partnership to repurchase up to 5% of the total issued and outstanding units, or 3,730,593 units. At the close of business on August 9, 2022, there were 74,611,871 units issued and outstanding. Under the normal course issuer bid, Brookfield Business Partners may purchase up to 17,678 units on the TSX during any trading day. Repurchases are authorized to commence on August 17, 2022 and will terminate on August 16, 2023, or earlier. Brookfield Business Partners will enter into an automatic purchase plan on or about the week of September 26 in relation to the normal course issuer bid.

06:55 EDT Avient to sell distribution business for $950M in cash - Avient announced it has entered into a definitive agreement to sell its distribution business to an affiliate of H.I.G. Capital for $950M in cash, subject to regulatory approval. On April 20, the company announced it was exploring a sale of its Distribution business, in connection with announcing an agreement to acquire the Protective Materials business of DSM. The company recently completed that process, culminating in the announcement. The company noted that after-tax proceeds of approximately $750M from the sale will be used to pay down near-term maturing debt. Pro forma for the sale of the distribution business and the forthcoming acquisition of DSM's Protective Materials business, net debt to adjusted EBITDA leverage will be approximately 2.8x at the end of the year.

06:37 EDT Fisker sells out of 2023 planned production of two trim levels for U.S. market - Fisker sold out two trim levels destined for the U.S. for its Fisker Ocean SUV: the $37,4991 Fisker Ocean Sport and the $49,9991 Fisker Ocean Ultra. Last month, Fisker sold out of the $68,9991 Fisker Ocean One limited edition globally, securing $5,0002 deposits from 5,000 reservation holders in 30 days. Starting on November 18, the day after start of production, Fisker will begin taking orders for the Fisker Ocean Extreme in select global launch markets, followed by opening orders for the Ultra and Sport trims in Q1 2023 for other launch markets outside the US. Earlier this month, Fisker reached out to US reservation holders regarding retaining eligibility for the $7,500 federal tax credit should the Inflation Reduction Act of 2022 become law. Fisker believes such a contract enables the customer to retain eligibility for a $7,500 federal tax credit for EVs that becomes unavailable if the IRA is signed into law. This ordering system remains in effect only until the IRA is passed and signed into law or is otherwise finally decided. Fisker is in discussions with its production partner Magna, examining the possibility of increasing production of the Fisker Ocean in the second half of 2023, potentially releasing more Fisker Ocean Ultra and Sport trims for the US market toward the end of 2023.

06:32 EDT Azure Power signs master supply agreement with Siemens Gamesa - Azure Power announced that it has signed a master supply agreement, or MSA, with Siemens Gamesa. Siemens Gamesa will supply 96 units of SG 3.6-145 onshore wind turbines which will cater to an overall capacity of approximately 346 MW wind projects. The turbine supply is expected to commence during Q2 CY 2023.

06:17 EDT Harsco CFO Anshooman Aga stepping down, Pete Minan named Interim CFO - Harsco CFO Anshooman Aga has resigned as Senior VP and CFO, effective August 24, to pursue employment with another company. Aga's departure did not result from any disagreement regarding the Company's corporate strategy, financial statements or disclosures. Pete Minan, Harsco's former CFO, has been appointed Interim Senior VP and CFO, effective August 29, until a permanent replacement for Aga is announced. Harsco will initiate a comprehensive search for a new CFO.

06:05 EDT Sinopec to delist shares from NYSE - Sinopec announced that the company has notified the NYSE on August 12 that it will apply for the voluntary delisting of its American depositary shares from the NYSE under the U.S. Securities Exchange Act of 1934, as amended. The board of directors of the company approved the delisting of its ADSs from NYSE as well as the application for the deregistration of such ADSs and the underlying H Shares, where such application is subject to the company satisfying the relevant requirements of the Exchange Act and depends on the relevant actual circumstances in the future. The determination of the board was based on several comprehensive considerations, including the small volume of the underlying H Shares of its outstanding ADSs compared to the total volume of its H Shares, the limited trading volume of its ADSs relative to the worldwide trading volume of its H Shares and the considerable administrative burden of maintaining the listing of the ADSs on the NYSE, the registration of the ADSs and the underlying H Shares with the United States Securities and Exchange Commission and complying with the periodic reporting and related obligations of the Exchange Act in the long term.

06:03 EDT Rogers Communications, Shaw, Quebecor sign pact for sale of Freedom Mobile - Rogers Communications (RCI), Shaw Communications (SJR) and Quebecor announced that they have entered into a definitive agreement for the sale of Freedom Mobile to Videotron Ltd., a subsidiary of Quebecor, subject to regulatory approvals and closing of the merger of Shaw and Rogers announced on March 15, 2021.The parties strongly believe the Freedom Transaction provides the best opportunity to create a strong fourth national wireless services provider and addresses the concerns raised by the Commissioner of Competition and the Minister of Innovation, Science and Industry regarding the Rogers-Shaw Transaction. With this Agreement, the new combined business of Videotron and Freedom will be well-positioned to launch a strong, competitive national 5G offering, using Videotron's 3500 MHz holdings. Accordingly, the parties believe the Rogers-Shaw Transaction should now be approved. This definitive agreement is substantially consistent with the terms previously announced on June 17. Rogers' standalone financial guidance for 2022, provided on April 20, remains unchanged.